Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bright Minds Biosciences Inc. - common stock
(NQ:
DRUG
)
76.06
+2.03 (+2.74%)
Streaming Delayed Price
Updated: 1:01 PM EDT, Jul 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
227,526
Open
73.29
Bid (Size)
76.07 (100)
Ask (Size)
76.77 (100)
Prev. Close
74.03
Today's Range
71.01 - 76.62
52wk Range
24.00 - 123.75
Shares Outstanding
11,834,361
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
May 26, 2026
From
Bright Minds Biosciences
Via
GlobeNewswire
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1
↗
May 26, 2026
Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases.
Via
The Motley Fool
Topics
Regulatory Compliance
Stocks
Performance
YTD
-8.9%
-8.9%
1 Month
+28.5%
+28.5%
3 Month
-14.7%
-14.7%
6 Month
-14.9%
-14.9%
1 Year
+196.5%
+196.5%
More News
Read More
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
↗
May 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
Regulatory Compliance
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
↗
May 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Neurocrine Biosciences to Acquire Celeno Therapeutics in Rare Disease Deal
April 07, 2026
Via
MarketMinute
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
January 09, 2026
From
Bright Minds Biosciences
Via
GlobeNewswire
The market is filled with gapping stocks in Wednesday's session.
↗
January 07, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
January 06, 2026
Via
Chartmill
Why Did DRUG Stock Rocket 51% Today?
↗
January 06, 2026
Via
Stocktwits
Stay updated with the stocks that are on the move in today's pre-market session.
↗
January 06, 2026
Via
Chartmill
Why Bright Minds Biosciences Stock Topped the Market on Monday
↗
November 17, 2025
Via
The Motley Fool
Large Patient Population Is Key Driver For Bright Minds' Growth
↗
September 08, 2025
Via
Benzinga
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside
↗
May 07, 2025
Via
Benzinga
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
March 04, 2025
From
Bright Minds Biosciences
Via
GlobeNewswire
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
February 24, 2025
From
Bright Minds Biosciences
Via
GlobeNewswire
Biotechs on the Brink: 2 Stocks With Huge Potential
February 14, 2025
Via
MarketBeat
This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
January 23, 2025
Via
Benzinga
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
January 07, 2025
From
Bright Minds Biosciences
Via
GlobeNewswire
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
November 21, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month
↗
November 13, 2024
Via
The Motley Fool
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
November 04, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
↗
November 04, 2024
Via
Benzinga
Topics
Government
What's Going On With Bright Minds Biosciences Stock?
↗
October 21, 2024
Via
Benzinga
Topics
Artificial Intelligence
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
October 21, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
MarketBeat Week in Review – 10/14 - 10/18
October 19, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Frequently Asked Questions
Is Bright Minds Biosciences Inc. - common stock publicly traded?
Yes, Bright Minds Biosciences Inc. - common stock is publicly traded.
What exchange does Bright Minds Biosciences Inc. - common stock trade on?
Bright Minds Biosciences Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bright Minds Biosciences Inc. - common stock?
The ticker symbol for Bright Minds Biosciences Inc. - common stock is DRUG on the Nasdaq Stock Market
What is the current price of Bright Minds Biosciences Inc. - common stock?
The current price of Bright Minds Biosciences Inc. - common stock is 76.06
When was Bright Minds Biosciences Inc. - common stock last traded?
The last trade of Bright Minds Biosciences Inc. - common stock was at 07/15/26 01:01 PM ET
What is the market capitalization of Bright Minds Biosciences Inc. - common stock?
The market capitalization of Bright Minds Biosciences Inc. - common stock is 900.12M
How many shares of Bright Minds Biosciences Inc. - common stock are outstanding?
Bright Minds Biosciences Inc. - common stock has 900M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
